Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoverageVideo

VIDEO: Short-course chemoradiation trial results could change standard of care in advanced rectal cancer

January 25, 2016
SAN FRANCISCO — Daniel Chang, MD, associate professor of radiation oncology at Stanford University, discusses randomized controlled trial data…
Meeting News CoverageVideo

VIDEO: Screening for Barrett's esophagus not feasible with current methods

January 23, 2016
SAN FRANCISCO — Kenneth Wang, MD, from the Mayo Clinic in Rochester, Minn., discusses his talk given as part of a debate on whether or not to…
Meeting News CoverageVideo

VIDEO: Expert discusses current issues in colonoscopic colorectal cancer screening

January 23, 2016
SAN FRANCISCO — Douglas K. Rex, MD, MACP, MACG, FASGE, AGAF, from Indiana University School of Medicine, discusses his presentation on novel…
Meeting News Coverage

Adjuvant therapy performed at high-volume center improved OS in pancreatic cancer

January 23, 2016
SAN FRANCISCO — Among patients with resected pancreatic cancer, overall survival was significantly better when adjuvant therapy was performed…
Meeting News CoveragePerspective

Nivolumab monotherapy shows promise in treating gastric, GE junction cancers

January 22, 2016
SAN FRANCISCO — Nivolumab monotherapy was well tolerated and showed antitumor activity in patients with advanced and metastatic gastric or…
Meeting News CoverageVideo

VIDEO: Expert discusses H. pylori-associated gastric cancer mechanisms, research

January 22, 2016
SAN FRANCISCO — Keith T. Wilson, MD, from Vanderbilt University Medical Center, discusses his keynote lecture on Helicobacter
Meeting News CoveragePerspective

CarPac pre-op chemoradiation benefits patients with resectable esophageal cancer

January 22, 2016
SAN FRANCISCO — After induction therapy, patients with resectable esophageal adenocarcinoma achieved superior pathological complete response…
Meeting News CoveragePerspective

Advanced gastric cancer patients may have better overall survival with mFOLFOX7 followed by mFOLFIRI

January 21, 2016
SAN FRANCISCO — First-line treatment with modified FOLFOX7 or modified FOLFIRI chemotherapy resulted in comparable progression-free survival…
Meeting News CoverageVideo

VIDEO: BE screening only feasible in high-risk patients until better techniques become available

January 21, 2016
SAN FRANCISCO — Gary W. Falk, MD, from the University of Pennsylvania Perelman School of Medicine and the Abramson Cancer Center, discusses…
Meeting News Coverage

Everolimus delays progression of neuroendocrine tumors

January 20, 2016
Everolimus appeared to delay the progression of neuroendocrine tumors that originate in the gastrointestinal tract or are of unknown origin…